谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial.

Paolo A. Ascierto,Reinhard Dummer,Helen J. Gogas,Ana Arance,Mario Mandala,Gabriella Liszkay,Claus Garbe,Dirk Schadendorf,Ivana Krajsova,Ralf Gutzmer,Vanna Chiarion-Sileni,Caroline Dutriaux,Jan Willem B. de Groot,Naoya Yamazaki,Carmen Loquai,Caroline Robert,Keith T. Flaherty

Journal of clinical oncology（2023）

引用 2|浏览36
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要